Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Broadcom
AVGO
|
$67.3M |
| 2 |
Veralto
VLTO
|
$60.2M |
| 3 |
Newmont
NEM
|
$43.4M |
| 4 |
Vertiv
VRT
|
$19.4M |
| 5 |
Webster Financial
WBS
|
$17.3M |
Top Sells
| 1 |
Apple
AAPL
|
$328M |
| 2 |
Microsoft
MSFT
|
$244M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$237M |
| 4 |
VMW
VMware, Inc
VMW
|
$130M |
| 5 |
NVIDIA
NVDA
|
$109M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.37% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENFN
2451
DELISTED
Enfusion, Inc.
ENFN
| $564K | ﹤0.01% |
58,100
+8,600
| +17% | +$83.4K |
|
2452
AnaptysBio
ANAB
$613M
| $561K | ﹤0.01% |
26,200
-11,700
| -31% | -$251K |
|
2453
Excelerate Energy
EE
$758M
| $560K | ﹤0.01% |
36,200
-4,200
| -10% | -$64.9K |
|
2454
Greif Class B
GEF.B
$2.5B
| $554K | ﹤0.01% |
8,400
-1,000
| -11% | -$66K |
|
2455
Edgewise Therapeutics
EWTX
$1.64B
| $548K | ﹤0.01% |
+50,100
| New | +$548K |
|
2456
Seneca Foods Class A
SENEA
$765M
| $545K | ﹤0.01% |
10,400
-1,100
| -10% | -$57.7K |
|
2457
Cogent Biosciences
COGT
$1.82B
| $544K | ﹤0.01% |
92,600
-25,600
| -22% | -$151K |
|
2458
Children's Place
PLCE
$121M
| $543K | ﹤0.01% |
23,400
-2,300
| -9% | -$53.4K |
|
2459
Legacy Housing
LEGH
$670M
| $541K | ﹤0.01% |
21,444
| – | – |
|
|
CBL
2460
CBL Properties
CBL
$990M
| $540K | ﹤0.01% |
22,100
-2,300
| -9% | -$56.2K |
|
2461
Ribbon Communications
RBBN
$707M
| $538K | ﹤0.01% |
185,474
-17,200
| -8% | -$49.9K |
|
2462
Five Star Bancorp
FSBC
$702M
| $534K | ﹤0.01% |
20,396
-1,900
| -9% | -$49.7K |
|
2463
The Beauty Health Co
SKIN
$260M
| $529K | ﹤0.01% |
170,200
-17,300
| -9% | -$53.8K |
|
|
NXDR
2464
Nextdoor Holdings
NXDR
$802M
| $528K | ﹤0.01% |
279,200
+39,300
| +16% | +$74.3K |
|
|
AGEN
2465
Agenus
AGEN
$138M
| $526K | ﹤0.01% |
31,790
-2,715
| -8% | -$45K |
|
2466
iHeartMedia
IHRT
$315M
| $519K | ﹤0.01% |
194,200
-20,300
| -9% | -$54.2K |
|
2467
Stitch Fix
SFIX
$737M
| $517K | ﹤0.01% |
144,900
-10,500
| -7% | -$37.5K |
|
2468
Entravision Communication
EVC
$226M
| $517K | ﹤0.01% |
123,950
-12,500
| -9% | -$52.1K |
|
|
MGIC
2469
Magic Software Enterprises
MGIC
$964M
| $515K | ﹤0.01% |
53,447
-5,270
| -9% | -$50.8K |
|
2470
Phathom Pharmaceuticals
PHAT
$875M
| $511K | ﹤0.01% |
56,000
-4,200
| -7% | -$38.3K |
|
2471
Liberty Latin America Class A
LILA
$1.6B
| $509K | ﹤0.01% |
69,600
-9,400
| -12% | -$68.7K |
|
2472
Holley
HLLY
$469M
| $506K | ﹤0.01% |
104,000
| – | – |
|
2473
Enliven Therapeutics
ELVN
$1.19B
| $505K | ﹤0.01% |
36,473
-4,200
| -10% | -$58.1K |
|
2474
Soho House & Co
SHCO
$1.73B
| $503K | ﹤0.01% |
70,600
-6,900
| -9% | -$49.1K |
|
|
ITOS
2475
DELISTED
iTeos Therapeutics
ITOS
| $503K | ﹤0.01% |
45,900
-4,700
| -9% | -$51.5K |
|